Withdrawals due to adverse events · People with palmoplantar psoriasis
1 finding from 1 review
Clearance rate · People with palmoplantar psoriasis
NB‐UVB showed no clear difference in clearance rate compared with topical PUVA (low certainty).
1 finding from 1 review
Participant‐rated global improvement · People with chronic plaque or guttate psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · People with chronic plaque or guttate psoriasis
NB‐UVB plus retinoid showed no clear difference in percentage of participants reaching PASI 75 compared with PUVA plus retinoid (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · People with chronic plaque or guttate psoriasis
1 finding from 1 review
Clearance rate · People with chronic plaque or guttate psoriasis
NB‐UVB plus retinoid showed no clear difference in clearance rate compared with PUVA plus retinoid (low certainty).
1 finding from 1 review
Participant‐rated global improvement · people with chronic plaque psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · people with chronic plaque psoriasis
1 finding from 1 review
Withdrawals due to adverse events · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in withdrawal due to side‐effects compared with selective BB‐UVB (low certainty).
1 finding from 1 review
Percentage of participants reaching PASI 75 · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in percentage of participants reaching PASI 75 compared with oral PUVA (low certainty).
1 finding from 1 review
Clearance rate · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in clearance rate compared with selective BB‐UVB (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in withdrawal due to side‐effects compared with oral PUVA (low certainty).
1 finding from 1 review
Clearance rate · people with chronic plaque psoriasis
1 finding from 1 review
Participant‐rated global improvement · people with chronic plaque psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · people with chronic plaque psoriasis
1 finding from 1 review
Withdrawals due to adverse events · people with chronic plaque psoriasis
1 finding from 1 review
Clearance rate · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in clearance rate compared with bath PUVA (low certainty).
1 finding from 1 review
Participant‐rated global improvement · People with palmoplantar psoriasis
1 finding from 1 review
Pain reduction (VAS 0-10) · People with erosive oral lichen planus
Topical tacrolimus 0.1% ointment showed no clear difference in pain reduction (VAS 0-10) compared with topical clobetasol propionate 0.05% ointment; GRADE not reported.
1 finding from 1 review
Physician Global Assessment (Thongprasom score) · People with erosive oral lichen planus
0.1% triamcinolone acetonide in orabase showed no clear difference in physician Global Assessment (Thongprasom score) compared with ciclosporin solution; GRADE not reported.
1 finding from 1 review